Basic Information
| LncRNA/CircRNA Name | MEG3 |
| Synonyms | MEG3, FP504, GTL2, LINC00023, NCRNA00023, PRO0518, PRO2160, onco-lncRNA-83, prebp1 |
| Region | GRCh38_14:100779410-100861031 |
| Ensemble | ENSG00000214548 |
| Refseq | NR_002766 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | non-functioning pituitary adenoma |
| ICD-0-3 | C75.1 |
| Methods | qPCR, Cell transfection, Western blot, Northern blot, Flow cytometry assay etc. |
| Sample | NFA tissues, cell line (PDFS) |
| Expression Pattern | differential expression |
| Function Description | In this study, we introduced MEG3 expression into PDFS cells, derived from a human NFA, using both inducible and constitutively active expression systems. MEG3 expression significantly suppressed xenograft tumor growth in vivo in nude mice. When induced in culture, MEG3 caused cell cycle arrest at the G1 phase. In addition, inactivation of p53 completely abolished tumor suppression by MEG3, indicating that MEG3 tumor suppression is mediated by p53. |
| Pubmed ID | 26284494 |
| Year | 2015 |
| Title | Tumor suppression by MEG3 lncRNA in a human pituitary tumor derived cell line. |
External Links
| Links for MEG3 | GenBank HGNC NONCODE |
| Links for non-functioning pituitary adenoma | OMIM COSMIC |